Vladimir Popov

Mr. Vladimir Popov

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Biochemistry and Biophysics Reports
Verified
Journal Article
Open access
ANA.K. Nurgalieva
A.K. Nurgalieva
Vladimir PopovVladimir Popov
Vladimir Popov
VSVera Skripova
Vera Skripova
LBLeisan Bulatova
Leisan Bulatova
DSD.V. Savenkova
D.V. Savenkova
Ramziya KiyamovaRamziya Kiyamova
Ramziya Kiyamova
The high mortality rate from ovarian cancer is due to the asymptomatic nature of the course of the disease, which leads to the diagnosis of ovarian cancer in later stages. The sodium-dependent phosphate transporter NaPi2b encoded by SLC34A2 gene is expressed in 80–90% of epithelial ovarian cancers and used as a target for therapeutic antibodies XMT-1536, and XMT-1592, which are derived from MX35 antibodies and used in clinical trials for the treatment of ovarian and lung cancers. In this work, we aimed to evaluate NaPi2b as a molecular marker for diagnostics and predicting the course and outcome of ovarian cancer disease.

Verified
Journal Article
Open access
PDF file
Vladimir PopovVladimir Popov
Vladimir Popov
VLVelemir Lavrinenko
Velemir Lavrinenko
ELEkaterina Litau
Ekaterina Litau
ASAlena A. Shurova
Alena A. Shurova
MTMikhail Trofimov
Mikhail Trofimov
STStanislav F. Tyazhelnikov
Stanislav F. Tyazhelnikov
Cell Painting is a high-content imaging approach that enables systematic characterization of cellular responses to chemical perturbations through quantitative morphological profiling. Although this methodology has been widely applied in drug discovery and functional genomics, ovarian cancer models remain comparatively underrepresented in Cell Painting studies. In the present work, we established a Cell Painting workflow for OVCAR-3 ovarian cancer cells and applied it to the phenotypic profiling of 54 anticancer compounds representing diverse mechanisms of action. Cells were exposed to compounds under short- and prolonged-treatment conditions, followed by multiplex fluorescent staining, high-content imaging, feature extraction using CellProfiler, and computational analysis of the resulting morphological profiles. Profiles obtained at the two treatment durations were analyzed separately. For each compound, the treatment condition showing greater within-compound consistency in PCA space was additionally retained to construct a combined dataset. Morphological relationships were explored using Pearson correlation analysis, dimensionality reduction, and unsupervised clustering. Morphological profiles showed reproducible relationships among compounds. Compounds with related mechanisms showed greater morphological similarity than expected by chance, although substantial within-class heterogeneity remained. Statistically significant cluster enrichment was observed for microtubule-targeting agents and topoisomerase inhibitors, whereas other mechanism-related patterns were incomplete. Among the evaluated clustering approaches, Leiden and agglomerative clustering produced similar separation of the Combined dataset, with silhouette scores of 0.486 and 0.482, respectively. Cell Painting identified mechanism-associated but heterogeneous morphological responses in OVCAR-3 cells. The results support the use of this model for exploratory phenotypic profiling while highlighting the influence of exposure conditions and the limited ability of morphology alone to recover annotated molecular mechanisms.

6 January 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
MTMikhail Trofimov
Mikhail Trofimov
IBIlya P. Bulatov
Ilya P. Bulatov
VLVelemir Lavrinenko
Velemir Lavrinenko
Vladimir PopovVladimir Popov
Vladimir Popov
VPVarvara S. Petrova
Varvara S. Petrova
STStanislav Tyazhelnikov
Stanislav Tyazhelnikov
Background: Three-dimensional (3D) cancer models are currently essential tools in high-throughput screening (HTS), serving as a bridge between in vitro and in vivo approaches during drug development. Even though spheroids offer many advantages over 2D cultures, analyzing 3D cultures with heterogeneous morphology remains challenging due to the lack of standardized visualization techniques and multiparameter analysis. Methods: In this work, an optimized CellProfiler pipeline and a Python algorithm for weighting morphological features are used to visualize, extract, and analyze morphological data from spheroids derived from colorectal and pancreatic cancer cell lines with diverse morphologies (HCT116, LoVo, PANC-1, and CFPAC-1). Results: We developed a feature weighting process that combines multiple morphological parameters into a single metric using principal component analysis (PCA). There is a strong correlation between this process and a standard Alamar Blue proliferation assay (r = 0.89, ρ = 0.91, p < 0.001). Using this method, we were able to ascertain the IC50 values of substances that did not produce results in cell lines with heterogeneous morphology (LoVo and CFPAC-1) using a standard proliferation assay. Conclusions: By removing the need for tracer dyes, the resulting methodology may lower costs while accelerating preclinical drug development through informative multiparameter analysis of compound efficacy.

24 September 2026 in ACS Omega
Verified
Journal Article
Open access
Vladimir PopovVladimir Popov
Vladimir Popov
VPVarvara Petrova
Varvara Petrova
MTMikhail Trofimov
Mikhail Trofimov
IBIlya Bulatov
Ilya Bulatov
AEAlexander Efremov
Alexander Efremov
STStanislav Tyazhelnikov
Stanislav Tyazhelnikov
Three-dimensional (3D) spheroid models are increasingly used in cancer research because they reproduce several features of solid tumors that are not represented in conventional two-dimensional (2D) monolayer cultures. In the present study, we developed and optimized spheroid culture conditions for a panel of breast, ovarian, and gastric cancer cell lines grown on low-attachment plates. Spheroid formation, morphology, and growth behavior were assessed during culture, and the resulting models were used for the comparative testing of reference anticancer agents. The established assay framework was further applied to newly developed cyclin-dependent kinase 7 (CDK7) inhibitor candidates from our in-house compound library. Anticancer activity was evaluated by using AlamarBlue or PrestoBlue viability assays after prolonged drug exposure. Reproducible spheroid formation conditions were identified for the studied cell lines, although notable cell line-specific differences in morphology, growth behavior, and assay duration were observed. Comparative drug testing revealed differences in apparent sensitivity between 2D and 3D cultures depending on the cell line and compound. Several tested CDK7 inhibitor candidates reduced viability in the spheroid models, with iCDK7_1 showing the strongest activity across the evaluated panel. Overall, the study describes and applies a cell line-adapted 3D spheroid assay workflow for comparative evaluation of antiproliferative effects in breast, ovarian, and gastric cancer models.

Verified
Journal Article
Open access
PDF file
VLVelemir Lavrinenko
Velemir Lavrinenko
IDIlona Donskaya
Ilona Donskaya
Vladimir PopovVladimir Popov
Vladimir Popov
ELEkaterina Litau
Ekaterina Litau
VPVarvara Petrova
Varvara Petrova
STStanislav Tyazhelnikov
Stanislav Tyazhelnikov
Cell Painting screens usually profile compounds at a single fixed endpoint. Many drug responses, however, develop over days, and compounds whose phenotypes are weak or still forming at the chosen endpoint give unstable profiles that move between clusters in repeated experiments and blur the phenotypic map. We profiled 53 small molecules in HCT116 cells after 48 h and 8 days of exposure, each in two independent iterations, and represented every compound by the window in which its replicate profiles were more stable. The resulting stability-weighted Combined map separated phenotypic groups more clearly than either single window (silhouette score of the modal partition 0.360 versus 0.227 and 0.292). This gain exceeded random window assignment (p = 0.002), also under analysis parameters chosen without the Combined dataset (p = 0.001). The number of compounds with inconsistent cluster assignment between iterations decreased (6 versus 16 and 13 of 53), although less consistently across analysis settings. The approach distinguishes compounds whose phenotypes are captured reproducibly at 48 h, compounds captured more reproducibly at 8 days, and a convergent group for which both windows give similar profiles. It offers a practical way to add a prolonged exposure window to phenotypic screens and to prioritize compounds for follow-up.